Skip to main content
. 2024 May 6;130(12):1929–1935. doi: 10.1038/s41416-024-02700-z

Table 2.

Baseline trial characteristics.

Characteristic (no. of trials) Control (n) Intervention (n) Total (n)
Median age (5)a 68.5 [64–70]b 65.25 [62–68]b 67.5
Sex (6) Male 115 153 268
Female 71 87 158
Primary (6) Lung 110 119 229
Prostate 51 81 132
Breast 5 13 18
Colorectal 9 9 18
Other 11 18 29
Synchronous (5) Synchronous 169 225 423
Metachronous 2 1 3
Number of metastases 1-2 91 110 201
(5) 3-4 42 53 95
5 4 9 13

n number of patients.

aThe median of the medians.

bMedian age range.